Medaica develops AI and sensors
that detect audio biomarkers, enabling low-cost heart and lung diagnostics.
Cardiovascular disease is the
world’s #1 killer. 80% is preventable!
Medaica is turning that around.
Affordable @home self-screening
for patients unlocks access to early, life-saving diagnostics.
A heart exam you can do yourself from the comfort of your own home.
Households USA, EU & UK
Growth of Digital First
Physician Office Visits in USA
Adults visited a Dr. last year
For patients
1st Over-the-Counter (OTC), FDA-cleared, cardiopulmonary self-exam diagnostics platform under $50.
Heart health screening for a fraction of the cost of a typical doctor’s visit.
For Healthcare Professionals
1/10 cost of existing FDA-cleared sensors.
Interoperable patient, EHR and virtual platform.
Support for patient self-exams, in-clinic exams and virtual exams.
Patented multi-modal auscultation.
Patented exam streaming/real-time lossless audio.
Decision support and AI for murmur detection
Medaica cloud platform includes AI Diagnostics, 3rd Party research ecosystem, low-cost acoustic biomarkers sensors, Patient App (iOS & Android), and Healthcare Professional APP.
Lorem ipsum dolor sit amet consectetur. Vitae tempor at nec et. Lacus hendrerit aliquam scelerisque facilisis elementum. Pretium est risus cursus pulvinar cras eu.
Amet neque dignissim ac enim purus. Rutrum tempor nunc sagittis pretium vulputate.Lorem ipsum dolor sit amet consectetur. Vitae tempor at nec et. Lacus hendrerit aliquam scelerisque facilisis elementum. Pretium est risus cursus pulvinar cras eu. Amet neque dignissim ac enim purus. Rutrum tempor nunc sagittis pretium vulputate.
Lorem ipsum dolor sit amet consectetur. Vitae tempor at nec et. Lacus hendrerit aliquam scelerisque facilisis elementum.
No! There are companies with expensive and proprietary diagnostic tools for doctors or companies with limited telehealth 1.0 solutions. NO COMPANY has a platform with inexpensive FDA-cleared OTC sensors and interoperable software for patients to access value-based chronic cardiac and pulmonary diagnostics.
No! There are companies with expensive and proprietary diagnostic tools for doctors or companies with limited telehealth 1.0 solutions. NO COMPANY has a platform with inexpensive FDA-cleared OTC sensors and interoperable software for patients to access value-based chronic cardiac and pulmonary diagnostics.
No! There are companies with expensive and proprietary diagnostic tools for doctors or companies with limited telehealth 1.0 solutions. NO COMPANY has a platform with inexpensive FDA-cleared OTC sensors and interoperable software for patients to access value-based chronic cardiac and pulmonary diagnostics.
No! There are companies with expensive and proprietary diagnostic tools for doctors or companies with limited telehealth 1.0 solutions. NO COMPANY has a platform with inexpensive FDA-cleared OTC sensors and interoperable software for patients to access value-based chronic cardiac and pulmonary diagnostics.
No! There are companies with expensive and proprietary diagnostic tools for doctors or companies with limited telehealth 1.0 solutions. NO COMPANY has a platform with inexpensive FDA-cleared OTC sensors and interoperable software for patients to access value-based chronic cardiac and pulmonary diagnostics.
No! There are companies with expensive and proprietary diagnostic tools for doctors or companies with limited telehealth 1.0 solutions. NO COMPANY has a platform with inexpensive FDA-cleared OTC sensors and interoperable software for patients to access value-based chronic cardiac and pulmonary diagnostics.
No! There are companies with expensive and proprietary diagnostic tools for doctors or companies with limited telehealth 1.0 solutions. NO COMPANY has a platform with inexpensive FDA-cleared OTC sensors and interoperable software for patients to access value-based chronic cardiac and pulmonary diagnostics.
We are passionate about making remote care available to everyone, simply and affordably.
MEDAICA INC
170 S. Green Valley Parkway,
Suite 300Henderson NV 89012
USA
Subscribe to our newsletter
